The termination of the poison pill removes a takeover defense, but the Strategic Cooperation Agreement with Beretta Holding remains in place. Monitor for any further developments under that agreement, such as potential stake building or strategic transactions.
Price Chart
Executive Summary
Ruger terminated its shareholder rights plan (poison pill) effective immediately, accelerating the expiration from October 13, 2026 to September 16, 2026. The termination follows the satisfaction of regulatory conditions under the previously announced Strategic Cooperation Agreement with Beretta Holding S.A. The board determined an active rights plan is no longer necessary.
Key Facts
- Rights plan final expiration accelerated from October 13, 2026 to September 16, 2026
- Rights plan terminated at close of business on September 16, 2026
- Termination follows satisfaction of regulatory conditions under Strategic Cooperation Agreement with Beretta Holding S.A.
- Board unanimously approved the amendment; no shareholder action required
- Terms of the Strategic Cooperation Agreement with Beretta Holding remain unchanged
Financial Impact
No financial impact disclosed; termination of a shareholder rights plan is an administrative governance change with no direct monetary effect.
Risk Factors
- Removal of poison pill could make company more vulnerable to unsolicited takeover approaches
- No financial details of the Beretta Holding agreement have been disclosed
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001174947-26-000877 |
| Exhibit: ex4-1.htm | 0001174947-26-000877 |
| Exhibit: ex99-1.htm | 0001174947-26-000877 |
| Document: 0001174947-26-000877-index-headers.html | 0001174947-26-000877 |
| Document: 0001174947-26-000877-index.html | 0001174947-26-000877 |
| Document: 0001174947-26-000877.txt | 0001174947-26-000877 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | SC 13D/A | $50.10 | awaiting T+20 | — | $45.47 (−9.24%) |
Oct 20, 2026 6d ago | SC TO-T/A | $48.74 | awaiting T+20 | — | $45.47 (−6.71%) |
Oct 16, 2026 10d ago | SC TO-T/A | $45.90 | awaiting T+20 | — | $45.47 (−0.94%) |
Sep 16, 2026 5w ago | 8-K | $40.14 $42.94 | ▲ +6.98% | ▲ +5.52% | $45.47 (+13.28%) |
Jun 4, 2026 20w ago | 8-K | $39.39 $37.65 | ▼ −4.42% | ▼ −3.04% | $45.47 (+15.44%) |
May 21, 2026 22w ago | Insider Cluster | $40.04 $40.49 | ▲ +1.12% | ▲ +2.54% | $45.47 (+13.56%) |
May 15, 2026 23w ago | Insider Cluster | $39.47 $39.47 | · 0.00% | ▼ −2.12% | $45.47 (+15.20%) |
May 8, 2026 24w ago | 8-K | $39.04 $38.77 | ▲ +0.69% | ▲ +0.72% | $45.47 (−16.47%) |
May 4, 2026 25w ago | 8-K | $41.77 $38.84 | ▼ −7.01% | ▼ −11.97% | $45.47 (+8.86%) |
May 4, 2026 25w ago | DEFA14A | $40.99 $38.94 | ▼ −5.00% | ▼ −10.65% | $45.47 (+10.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers